HIG2 and Hypoxic Regulation of Protein Synthesis

HIG2 和蛋白质合成的缺氧调节

基本信息

  • 批准号:
    6766430
  • 负责人:
  • 金额:
    $ 25.21万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2004
  • 资助国家:
    美国
  • 起止时间:
    2004-04-01 至 2008-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Hypoxia is a unique patho-physiologic stress of the solid tumor that has been shown both experimentally and clinically to influence tumor aggressiveness, metastatic potential and response to therapy. The mechanisms for these phenomena have not been determined, but are thought to be at least partially dependent upon gene and protein expression changes induced by hypoxia. Investigators have identified many components of the hypoxic stress response cascade starting from hypoxic sensing, to transcriptional changes, to protein expression changes and post-translational protein modifications. Tumor cells that are unable to start new hypoxia-responsive mRNA transcription grow poorly in model tumors (HIF knockouts). Likewise, cells that fail to express the hypoxic target protein vascular endothelial growth factor also grow poorly in model tumors (VEGF knockouts). The conclusion can therefore be made that studying other components of the stress response cascade is reasonable, because blocking them could have similarly profound impact on tumor growth. We propose to investigate if HIG2 can influence stress-dependent protein synthesis because we have evidence that HIG2 is associated with translational machinery during hypoxia. We have previously identified HIG2 as a novel 63 amino acid proteins that is robustly induced by hypoxia in a wide variety of normal cells and tumor cell lines. We now show that the HIG2 protein co-localizes with members of the cytoplasmic "Stress granule". Stress granules have been shown to regulate protein translation in response to heat shock, and we suggest that they serve a similar function during hypoxia. This grant proposal is based upon the hypothesis that HIG2 plays an important function in regulating protein synthesis during hypoxia through its association with components of the stress granule. To address this hypothesis, we propose to 1) Identify the mechanism by which HIG2 is targeted to the stress granule, 2) Determine binding partners for HIG2 during hypoxia and 3) Establish the functional significance of HIG2 within the stress granule during tumor formation. These experiments should determine if HIG2 is necessary for hypoxia-dependent translational control, and how important this control is to the survival of ceils within the hypoxic regions of human tumors.
描述(由申请人提供):

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Nicholas C. Denko其他文献

Hypoxia, HIF1 and glucose metabolism in the solid tumour
实体瘤中的缺氧、HIF1 与葡萄糖代谢
  • DOI:
    10.1038/nrc2468
  • 发表时间:
    2008-08-14
  • 期刊:
  • 影响因子:
    66.800
  • 作者:
    Nicholas C. Denko
  • 通讯作者:
    Nicholas C. Denko
Hypoxic gene expression and metastasis
  • DOI:
    10.1023/b:canc.0000031768.89246.d7
  • 发表时间:
    2004-08-01
  • 期刊:
  • 影响因子:
    8.700
  • 作者:
    Quynh-Thu Le;Nicholas C. Denko;Amato J. Giaccia
  • 通讯作者:
    Amato J. Giaccia

Nicholas C. Denko的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Nicholas C. Denko', 18)}}的其他基金

Overcoming Hypoxic Resistance in Non-Small Cell Lung Cancer By Targeting Mitochondrial Metabolism
通过靶向线粒体代谢克服非小细胞肺癌的缺氧抵抗
  • 批准号:
    10275968
  • 财政年份:
    2021
  • 资助金额:
    $ 25.21万
  • 项目类别:
Overcoming Hypoxic Resistance in Non-Small Cell Lung Cancer By Targeting Mitochondrial Metabolism
通过靶向线粒体代谢克服非小细胞肺癌的缺氧抵抗
  • 批准号:
    10704677
  • 财政年份:
    2021
  • 资助金额:
    $ 25.21万
  • 项目类别:
Diversity Supplement R01CA262388: Overcoming Hypoxic Resistance in Non-Small Cell Lung Cancer By Targeting Mitochondrial Metabolism
多样性补充剂 R01CA262388:通过靶向线粒体代谢克服非小细胞肺癌的缺氧抵抗
  • 批准号:
    10595436
  • 财政年份:
    2021
  • 资助金额:
    $ 25.21万
  • 项目类别:
Overcoming Hypoxic Resistance in Non-Small Cell Lung Cancer By Targeting Mitochondrial Metabolism
通过靶向线粒体代谢克服非小细胞肺癌的缺氧抵抗
  • 批准号:
    10737837
  • 财政年份:
    2021
  • 资助金额:
    $ 25.21万
  • 项目类别:
Overcoming hypoxic resistance to anti-cancer therapy
克服抗癌治疗的缺氧抵抗
  • 批准号:
    10318987
  • 财政年份:
    2020
  • 资助金额:
    $ 25.21万
  • 项目类别:
Overcoming hypoxic resistance to anti-cancer therapy
克服抗癌治疗的缺氧抵抗
  • 批准号:
    10531898
  • 财政年份:
    2020
  • 资助金额:
    $ 25.21万
  • 项目类别:
A phase 0 pilot study to determine if papaverine increases oxygenation in spontaneous canine soft tissue sarcoma
一项 0 期试点研究,以确定罂粟碱是否会增加自发性犬软组织肉瘤的氧合
  • 批准号:
    9985010
  • 财政年份:
    2019
  • 资助金额:
    $ 25.21万
  • 项目类别:
SARRP 200 Small animal radiation research platform
SARRP 200 小动物辐射研究平台
  • 批准号:
    8826303
  • 财政年份:
    2015
  • 资助金额:
    $ 25.21万
  • 项目类别:
Decreasing oxygen metabolism to redcue hypoxia and radiosensitize tumors.
减少氧代谢以减少缺氧并使肿瘤放射增敏。
  • 批准号:
    8703638
  • 财政年份:
    2012
  • 资助金额:
    $ 25.21万
  • 项目类别:
Decreasing oxygen metabolism to redcue hypoxia and radiosensitize tumors.
减少氧代谢以减少缺氧并使肿瘤放射增敏。
  • 批准号:
    8700567
  • 财政年份:
    2012
  • 资助金额:
    $ 25.21万
  • 项目类别:

相似海外基金

Role of novel RNA binding protein LARP6 in alcoholic cardiomyopathy
新型RNA结合蛋白LARP6在酒精性心肌病中的作用
  • 批准号:
    10593688
  • 财政年份:
    2023
  • 资助金额:
    $ 25.21万
  • 项目类别:
Targeting of RNA-binding protein FXR1 in HNSCC
HNSCC 中 RNA 结合蛋白 FXR1 的靶向
  • 批准号:
    10571379
  • 财政年份:
    2023
  • 资助金额:
    $ 25.21万
  • 项目类别:
Mechanisms driving Autosomal Dominant Polycystic Kidney Disease: The novel role of the RNA-binding protein ANKHD1.
常染色体显性多囊肾病的驱动机制:RNA 结合蛋白 ANKHD1 的新作用。
  • 批准号:
    MR/T04201X/2
  • 财政年份:
    2023
  • 资助金额:
    $ 25.21万
  • 项目类别:
    Fellowship
Identify the role of RNA-binding protein in activating anti-tumor immunity by directly decaying PD-L1-3'UTR
通过直接降解 PD-L1-3UTR 鉴定 RNA 结合蛋白在激活抗肿瘤免疫中的作用
  • 批准号:
    23KJ1296
  • 财政年份:
    2023
  • 资助金额:
    $ 25.21万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Anti-inflammatory Signaling of RNA-binding Protein, Tristetraprolin, During Myocardial Infarction
RNA 结合蛋白 Tristetraprolin 在心肌梗死期间的抗炎信号传导
  • 批准号:
    10644962
  • 财政年份:
    2023
  • 资助金额:
    $ 25.21万
  • 项目类别:
Formation and function of pathologic stress granules containing RNA-Binding Protein SFPQ in tauopathy
tau蛋白病中含有RNA结合蛋白SFPQ的病理应激颗粒的形成和功能
  • 批准号:
    10581946
  • 财政年份:
    2023
  • 资助金额:
    $ 25.21万
  • 项目类别:
ERK-mediated regulation of RNA binding protein condensation during female germ cell development
ERK 介导的雌性生殖细胞发育过程中 RNA 结合蛋白凝聚的调节
  • 批准号:
    10514951
  • 财政年份:
    2022
  • 资助金额:
    $ 25.21万
  • 项目类别:
Role of RNA-binding protein in immune evasion of Mtb in macrophages
RNA结合蛋白在巨噬细胞中Mtb免疫逃避中的作用
  • 批准号:
    10634764
  • 财政年份:
    2022
  • 资助金额:
    $ 25.21万
  • 项目类别:
Post-transcriptional regulation by the YBX3 RNA-binding protein in skeletal muscle
骨骼肌中 YBX3 RNA 结合蛋白的转录后调节
  • 批准号:
    10439013
  • 财政年份:
    2022
  • 资助金额:
    $ 25.21万
  • 项目类别:
Evolution of RNA Binding Protein Regulation of Brain Development
RNA结合蛋白对大脑发育调节的进化
  • 批准号:
    2735241
  • 财政年份:
    2022
  • 资助金额:
    $ 25.21万
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了